Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Zongo, I."'
Autor:
Thompson, HA, Hogan, AB, Walker, PGT, Winskill, P, Zongo, I, Sagara, I, Tinto, H, Ouedraogo, J-B, Dicko, A, Chandramohan, D, Greenwood, B, Cairns, M, Ghani, AC
Publikováno v:
e1792
e1782
e1782
BACKGROUND: A 2021 clinical trial of seasonal RTS,S/AS01E (RTS,S) vaccination showed that vaccination was non-inferior to seasonal malaria chemoprevention (SMC) in preventing clinical malaria. The combination of these two interventions provided signi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce854b21cc2abe299665a14a8fd30fae
https://doi.org/10.1016/s2214-109x(22)00416-8
https://doi.org/10.1016/s2214-109x(22)00416-8
Autor:
Somé, A.F., Zongo, I., Sagara, I., Ibrahim, A., Ahanhanzo, C.D., Agbanouvi-Agassi, E.E., Sayi, D.A., Paré, L., Kabré, Z., Nikiéma, F., Bazié, T., Ouédraogo, S., Sombié, I., Dicko, A., Adehossi, E., Ouédraogo, J.B., Dabiré, K.R.
Publikováno v:
In Revue d'Epidemiologie et de Santé Publique September 2023 71 Supplement 3
Autor:
Thompson, H, Hogan, A, Walker, P, Winskill, P, Zongo, I, Sagara, I, Tinto, H, Ouedraogo, J-B, Dicko, A, Chandramohan, D, Greenwood, B, Cairns, M, Ghani, A
Background: A recent clinical trial of seasonal RTS,S/AS01E (RTS,S) vaccination showed that vaccination was non-inferior to seasonal malaria chemoprevention (SMC) in preventing clinical malaria. The combination of these two interventions provided sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::f59a9ad1927c34972d4d45424ad0ff99
http://hdl.handle.net/10044/1/99858
http://hdl.handle.net/10044/1/99858
Autor:
Chotsiri, P, Zongo, I, Milligan, P, Compaore, Y, Anyirékun Fabrice, S, Chandramohan, D, Hanpithakpong, W, Nosten, F, Greenwood, B, Rosenthal, P, White, N, Ouédraogo, J, Tarning, J
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Nature Communications
Nature Communications
Young children are the population most severely affected by Plasmodium falciparum malaria. Seasonal malaria chemoprevention (SMC) with amodiaquine and sulfadoxine-pyrimethamine provides substantial benefit to this vulnerable population, but resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::973f13b153f43fd6e2984012c7c36db2
https://doaj.org/article/86ec31b424e24336afbb7777111820e8
https://doaj.org/article/86ec31b424e24336afbb7777111820e8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chandramohan, D.1 daniel.chandramohan@Ishtm.ac.uk, Zongo, I.2, Sagara, I.3, Cairns, M.1, Yerbanga, R.-S.2, Diarra, M.3, Nikièma, F.2, Tapily, A.3, Sompougdou, F.2, Issiaka, D.3, Zoungrana, C.2, Sanogo, K.3, Haro, A.2, Kaya, M.3, Sienou, A.-A.2, Traore, S.3, Mahamar, A.3, Thera, I.3, Diarra, K.3, Dolo, A.3
Publikováno v:
New England Journal of Medicine. 9/9/2021, Vol. 385 Issue 11, p1005-1017. 13p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hoglund, RM, Workman, L, Edstein, MD, Thanh, NX, Quang, NN, Zongo, I, Ouedraogo, JB, Borrmann, S, Mwai, L, Nsanzabana, C, Price, RN, Dahal, P, Sambol, NC, Parikh, S, Nosten, F, Ashley, EA, Phyo, AA, Lwin, KM, McGready, R, Day, N, Guerin, PJ, White, NJ, Barnes, KI, Tarning, J
Publikováno v:
PLoS Medicine.
Background: Artemisinin-based combination therapies (ACTs) are the mainstay of the current treatment of uncomplicated P.falciparum malaria, but ACT resistance is spreading across Southeast Asia. Dihydroartemisinin-piperaquine is one of the five ACTs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::bf2252a4dbeae8095f24b664a85e47ab
http://ora.ox.ac.uk/objects/uuid:
http://ora.ox.ac.uk/objects/uuid:
Autor:
Hoglund, R, Workman, L, Edstein, M, Thanh, N, Quang, N, Zongo, I, Ouedraogo, J, Borrmann, S, Mwai, L, Nsanzabana, C, Price, R, Dahal, P, Nosten, F, Ashley, E, Phyo, A, Lwin, K, McGready, R, Day, N, Guerin, P, White, N, Barnes, K, Tarning, J
Background: Artemisinin-based combination therapies (ACTs) are the mainstay of the current treatment of uncomplicated P.falciparum malaria, but ACT resistance is spreading across Southeast Asia. Dihydroartemisinin-piperaquine is one of the five ACTs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::be7087f050650117f11a0d36c17d7f41
https://doi.org/10.1371/journal.pmed.1002212
https://doi.org/10.1371/journal.pmed.1002212